FDA Approves GSK’s Whooping Cough Vaccine During Pregnancy For Prevention In Infants
The FDA has approved GSK Plc’s (NYSE:GSK) Boostrix vaccine during the third trimester of pregnancy to prevent whooping cough in infants…
BrainStorm Presents New Biomarker Analyses From NurOwn’s Phase 3 ALS Trial At The ALS ONE Research Symposium
NurOwn® drove biomarker responses, affecting pathways related to neurodegeneration, neuroinflammation, and neuroprotection, that were consistent in participants with both advanced ALS and less advanced disease,
Alnylam’s Lumasiran Scores Expanded FDA Approval For Ultra Rare Genetic Disease
The FDA approved a label expansion for Alnylam Pharmaceuticals Inc’s (NASDAQ:ALNY) for Oxlumo (lumasiran), an RNAi therapeutic administered via subcutaneous injection, now…
Amid FDA Dispute, Juul Labs Cancels Overseas Expansion Plans, Refinances Some Debt
Juul Labs Inc's CEO, K.C. Crosthwaite, said the company is taking all necessary steps to keep it afloat. Altria Group Inc (NYSE: MO) has a minority stake in the company.
Lyell Immunopharma Announces FDA Clearance Of Its IND For LYL845, A TIL Product Candidate Enhanced With Its Novel Epigenetic Reprogramming Technology For Solid Tumors
Autologous TIL therapy enhanced with Lyell's Epi-R™ reprogramming technology designed to create polyclonal T cell populations with properties of durable stemness and improved function
Phase 1 trial
Eli Lilly’s Obesity Drug, Tirzepatide, Fast Tracked In US; Rolling Submission To Start This Year
The FDA has granted Fast Track designation for Eli Lilly And Co’s (NYSE: LLY) tirzepatide for adults with obesity or overweight with weight-related…
Desktop Health Receives FDA Clearance For SmileGuard Resin For Durable And Comfortable Orthodontic And Dental Appliances
Dentists and labs can use proprietary SmileGuard resin to 3D print bite splints, night guards, and mouth guards in the office in as little as one hour, allowing same-day delivery
Compared to other 3D printed